(Q71835678)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944278%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Lipid formulations of amphotericin b in the treatment of experimental visceral leishmaniasis due to Leishmania infantum (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944278%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

main subject

visceral leishmaniasis

1 reference

1 reference

1 reference

J P Gangneux

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944278%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A Sulahian

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944278%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Y J Garin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944278%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

F Derouin

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944278%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 September 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944278%20AND%20SRC:MED&resulttype=core&format=json

Transactions of the Royal Society of Tropical Medicine and Hygiene

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944278%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944278%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944278%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

574-577

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944278%20AND%20SRC:MED&resulttype=core&format=json

Treatment of murine candidosis and cryptococcosis with a unilamellar liposomal amphotericin B formulation (AmBisome)

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Efficacy and tolerance of an amphotericm B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Amphotericin B lipid complex therapy of experimental fungal infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Leishmaniasis: some recent developments in chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Liposomal amphotericin B in the treatment of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Liposomal amphotericin B in drug-resistant visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Clinical use of liposomal and lipid-complexed amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Treatment with liposomal amphotericin B of a child affected with drug-resistant visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Activity of liposomal amphotericin B (AmBisome) against Leishmania infantum and tissue distribution in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Administering amphotericin B--a practical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Liposomal amphotericin B for leishmaniasis treatment of AIDS patients unresponsive to antimonium compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Visceral leishmaniasis and HIV-1 co-infection in southern France

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Lipid-based formulations of amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990330-2

7 January 2021

10.1016/S0035-9203(96)90330-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944278%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference